Clinical trial
Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents
NCT01356758 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents
- Lead sponsor
- University of Aarhus
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- November 30, 2015
- Enrollment
- 126 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerosis, atopic dermatitis, psoriasis